Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Mats Wahlstrom reported a 9.00% stake in Trisalus Life Sciences, Inc. (Schedule 13D/A)
Event Dec 17, 2024 · Filed Dec 19, 2024
Mats Wahlstrom reported a 9.00% stake in Trisalus Life Sciences, Inc., 2,797,437 shares, with active intent on Dec 17, 2024. Filed Dec 19, 2024 (Schedule 13D/A).
- Stake
- 9.00%
- Shares
- 2,797,437
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mats Wahlstrom | 9.00% | 2,797,437 |
| Kerry R. Hicks | 7.50% | 2,320,240 |
| HW Investment Partners, LLC | 4.50% | 1,370,028 |
Source
Related
- Trisalus Life Sciences, Inc.
- Wahlstrom Mats
- Trisalus Life Sciences, Inc. shareholders
- Schedule 13D/A · Wahlstrom Mats · Aug 1, 2025
- Form 4 · Cox Bryan F. · Oct 7, 2026
- Form 4 · Marshak Richard · Oct 7, 2026
- Form 4 · Stevens Jennifer · Oct 7, 2026
- Form 4 · Szela Mary T · Oct 7, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Jul 7, 2026